Parameters | Sample (n) | Total cohort | Transient AKI | Persistent AKI | p value |
---|---|---|---|---|---|
[TIMP-2]*[IGFBP7] at 0 h ([ng/ml]2/1000) | 184 | 1.26 [0.26–4.00] | 0.75 [0.20–2.12] | 2.21 [0.81–4.90] | < 0.001 |
[TIMP-2]*[IGFBP7] at 6 h ([ng/ml]2/1000) | 172 | 0.71 [0.22–2.86] | 0.37 [0.13–1.38] | 2.02 [0.54–5.43] | < 0.001 |
[TIMP-2]*[IGFBP7] at 12 h ([ng/ml]2/1000) | 165 | 0.50 [0.19–1.59] | 0.33 [0.13–0.78] | 1.19 [0.30–3.8] | < 0.001 |
[TIMP-2]*[IGFBP7] at 24 h ([ng/ml]2/1000) | 156 | 0.46 [0.16–1.18] | 0.32 [0.12–0.86] | 0.69 [0.26–2.36] | < 0.001 |
∆[TIMP-2]*[IGFBP7] 0 to 6 h (%) | 172 | − 20.0 [− 76.4–74.7] | 11.3 [− 48.6–111.1] | − 36.5 [− 79.4–49.7] | 0.04 |
∆[TIMP-2]*[IGFBP7] 0 to 12 h (%) | 165 | − 39.1 [− 77.2–56.4] | − 19.0 [− 70.6–100.4] | − 50.0 [− 84.0–50.0] | 0.13 |
∆[TIMP-2]*[IGFBP7] 12 to 24 h (%) | 156 | 0.0 [− 77.3–56.4] | 3.7 [− 76.0–48.7] | 0.0 [− 66.7–51.5] | 0.99 |